- Home
- CMCL vs CDXS Comparison
CMCL vs CDXS Comparison
Compare CMCL & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- CDXS
- Stock Information
- Founded
- CMCL 1992
- CDXS 2002
- Country
- CMCL Jersey
- CDXS United States
- Employees
- CMCL N/A
- CDXS N/A
- Industry
- CMCL Precious Metals
- CDXS Major Chemicals
- Sector
- CMCL Basic Materials
- CDXS Industrials
- Exchange
- CMCL Nasdaq
- CDXS Nasdaq
- Market Cap
- CMCL 310.6M
- CDXS 332.0M
- IPO Year
- CMCL N/A
- CDXS 2010
- Fundamental
- Price
- CMCL $10.74
- CDXS $4.61
- Analyst Decision
- CMCL Buy
- CDXS Buy
- Analyst Count
- CMCL 1
- CDXS 2
- Target Price
- CMCL $13.50
- CDXS $11.00
- AVG Volume (30 Days)
- CMCL 94.1K
- CDXS 717.6K
- Earning Date
- CMCL 11-11-2024
- CDXS 10-31-2024
- Dividend Yield
- CMCL 5.22%
- CDXS N/A
- EPS Growth
- CMCL N/A
- CDXS N/A
- EPS
- CMCL 0.48
- CDXS N/A
- Revenue
- CMCL $165,346,000.00
- CDXS $64,446,000.00
- Revenue This Year
- CMCL $31.50
- CDXS N/A
- Revenue Next Year
- CMCL $9.45
- CDXS $2.02
- P/E Ratio
- CMCL $22.18
- CDXS N/A
- Revenue Growth
- CMCL 22.97
- CDXS N/A
- 52 Week Low
- CMCL $8.91
- CDXS $1.85
- 52 Week High
- CMCL $16.95
- CDXS $4.91
- Technical
- Relative Strength Index (RSI)
- CMCL 24.91
- CDXS 73.88
- Support Level
- CMCL $10.81
- CDXS $3.70
- Resistance Level
- CMCL $15.81
- CDXS $4.20
- Average True Range (ATR)
- CMCL 0.70
- CDXS 0.31
- MACD
- CMCL -0.30
- CDXS 0.05
- Stochastic Oscillator
- CMCL 0.69
- CDXS 93.50
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.